… -risk hypertension and heart failure with reduced ejection fraction, … in hypertension and heart
failure with reduced ejection … cardiovascular disease from hypertension to heart failure (HF). …

… and hyperkalemia) in heart failure is common because of heart failure itself, related …
Hypokalemia is associated with excess morbidity and mortality in heart failure. The lower the K + …

… Iron deficiency (ID) is one of the most frequent comorbidities in patients with heart failure (HF).
ID is estimated to be present in up to 50% of outpatients and is a strong independent …

… Thus, defining whether a flavonoid has therapeutic potential solely by its structure and
chemical groups with antioxidant potential is not adequate to take full advantage of plant …

… This review provides evidence regarding the potential effects of ginger against SARS-CoV-2
infection and highlights its antiviral, anti-inflammatory, antioxidative, and …

… Accordingly, restoration of the NO–sGC–cGMP pathway is an attractive pharmacological target
for heart failure therapy… To test the therapeutic potential of riociguat, we first induced heart …

… the management of patients with heart failure. Despite a large … management of patients with
heart failure. We discuss high-… Furthermore, we discuss potential implementation in clinical …

… Heart failure is considered an epidemic disease in the modern world affecting … stage heart
failure; however, cardiac allotransplantation is limited by a severe global donor heart shortage […

… We also discussed potential biomarkers with therapeutic potential, and representative studies
are illustrated in Figure 2. Representative studies of the prognostic value of OS biomarkers …

… A bidirectional pathophysiological link connects heart failure and atrial fibrillation, creating a
… most of the established treatment measures for heart failure as well as rhythm or rate control …